279 related articles for article (PubMed ID: 33910427)
1. Novel advances in biotransformation and bioactivation research - 2020 year in review.
Khojasteh SC; Argikar UA; Driscoll JP; Heck CJS; King L; Jackson KD; Jian W; Kalgutkar AS; Miller GP; Kramlinger V; Rietjens IMCM; Teitelbaum AM; Wang K; Wei C
Drug Metab Rev; 2021 Aug; 53(3):384-433. PubMed ID: 33910427
[TBL] [Abstract][Full Text] [Related]
2. Bioactivation and reactivity research advances - 2021 year in review.
Jackson KD; Argikar UA; Cho S; Crouch RD; Driscoll JP; Heck CJS; King L; Maw HH; Miller GP; Seneviratne HK; Wang S; Wei C; Zhang D; Khojasteh SC
Drug Metab Rev; 2022 Aug; 54(3):246-281. PubMed ID: 35876116
[TBL] [Abstract][Full Text] [Related]
3. Novel advances in biotransformation and bioactivation research-2019 year in review
Khojasteh SC; Driscoll JP; Jackson KD; Miller GP; Mitra K; Rietjens IMCM; Zhang D
Drug Metab Rev; 2020 Aug; 52(3):333-365. PubMed ID: 32645275
[TBL] [Abstract][Full Text] [Related]
4. Biotransformation and bioactivation reactions - 2018 literature highlights.
Khojasteh SC; Bumpus NN; Driscoll JP; Miller GP; Mitra K; Rietjens IMCM; Zhang D
Drug Metab Rev; 2019 May; 51(2):121-161. PubMed ID: 31170851
[TBL] [Abstract][Full Text] [Related]
5. Biotransformation novel advances - 2021 year in review.
Khojasteh SC; Argikar UA; Cho S; Crouch R; Heck CJS; Johnson KM; Kalgutkar AS; King L; Maw HH; Seneviratne HK; Wang S; Wei C; Zhang D; Jackson KD
Drug Metab Rev; 2022 Aug; 54(3):207-245. PubMed ID: 35815654
[TBL] [Abstract][Full Text] [Related]
6. Biotransformation research advances - 2022 year in review.
Khojasteh SC; Argikar UA; Cheruzel L; Cho S; Crouch RD; Dhaware D; Heck CJS; Johnson KM; Kalgutkar AS; King L; Liu J; Ma B; Maw H; Miller GP; Seneviratne HK; Takahashi RH; Wang S; Wei C; Jackson KD
Drug Metab Rev; 2023 Nov; 55(4):301-342. PubMed ID: 37737116
[TBL] [Abstract][Full Text] [Related]
7. Biotransformation and bioactivation reactions - 2016 literature highlights.
Khojasteh SC; Rietjens IMCM; Dalvie D; Miller G
Drug Metab Rev; 2017 Aug; 49(3):285-317. PubMed ID: 28468514
[TBL] [Abstract][Full Text] [Related]
8. Biotransformation and bioactivation reactions - 2015 literature highlights.
Baillie TA; Dalvie D; Rietjens IM; Cyrus Khojasteh S
Drug Metab Rev; 2016 May; 48(2):113-38. PubMed ID: 27362326
[TBL] [Abstract][Full Text] [Related]
9. Biotransformation and bioactivation reactions - 2017 literature highlights
Khojasteh SC; Miller GP; Mitra K; Rietjens IMCM
Drug Metab Rev; 2018 Aug; 50(3):221-255. PubMed ID: 29954222
[TBL] [Abstract][Full Text] [Related]
10. Biotransformation and bioactivation reactions of alicyclic amines in drug molecules.
Bolleddula J; DeMent K; Driscoll JP; Worboys P; Brassil PJ; Bourdet DL
Drug Metab Rev; 2014 Aug; 46(3):379-419. PubMed ID: 24909234
[TBL] [Abstract][Full Text] [Related]
11. Biotransformation of the anthraquinones emodin and chrysophanol by cytochrome P450 enzymes. Bioactivation to genotoxic metabolites.
Mueller SO; Stopper H; Dekant W
Drug Metab Dispos; 1998 Jun; 26(6):540-6. PubMed ID: 9616189
[TBL] [Abstract][Full Text] [Related]
12. Streptomyces cytochromes P450: applications in drug metabolism.
Lamb DC; Waterman MR; Zhao B
Expert Opin Drug Metab Toxicol; 2013 Oct; 9(10):1279-94. PubMed ID: 23738914
[TBL] [Abstract][Full Text] [Related]
13. Biotransformation of endocrine disrupting compounds by selected phase I and phase II enzymes--formation of estrogenic and chemically reactive metabolites by cytochromes P450 and sulfotransferases.
Reinen J; Vermeulen NP
Curr Med Chem; 2015; 22(4):500-27. PubMed ID: 25245506
[TBL] [Abstract][Full Text] [Related]
14. Unusual Biotransformation Reactions of Drugs and Drug Candidates.
Isin EM
Drug Metab Dispos; 2023 Apr; 51(4):413-426. PubMed ID: 36653118
[TBL] [Abstract][Full Text] [Related]
15. Non-cytochrome P450-mediated bioactivation and its toxicological relevance.
Gan J; Ma S; Zhang D
Drug Metab Rev; 2016 Nov; 48(4):473-501. PubMed ID: 27533622
[TBL] [Abstract][Full Text] [Related]
16. Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism.
Pirmohamed M; Madden S; Park BK
Clin Pharmacokinet; 1996 Sep; 31(3):215-30. PubMed ID: 8877251
[TBL] [Abstract][Full Text] [Related]
17. Going Beyond Common Drug Metabolizing Enzymes: Case Studies of Biotransformation Involving Aldehyde Oxidase, γ-Glutamyl Transpeptidase, Cathepsin B, Flavin-Containing Monooxygenase, and ADP-Ribosyltransferase.
Fan PW; Zhang D; Halladay JS; Driscoll JP; Khojasteh SC
Drug Metab Dispos; 2016 Aug; 44(8):1253-61. PubMed ID: 27117704
[TBL] [Abstract][Full Text] [Related]
18. Detoxication versus Bioactivation Pathways of Lapatinib In Vitro: UGT1A1 Catalyzes the Hepatic Glucuronidation of Debenzylated Lapatinib.
Nardone-White DT; Bissada JE; Abouda AA; Jackson KD
Drug Metab Dispos; 2021 Mar; 49(3):233-244. PubMed ID: 33376146
[No Abstract] [Full Text] [Related]
19. Metabolic map and bioactivation of the anti-tumour drug noscapine.
Fang ZZ; Krausz KW; Li F; Cheng J; Tanaka N; Gonzalez FJ
Br J Pharmacol; 2012 Nov; 167(6):1271-86. PubMed ID: 22671862
[TBL] [Abstract][Full Text] [Related]
20. Bioactivation of phencyclidine in rat and human liver microsomes and recombinant P450 2B enzymes: evidence for the formation of a novel quinone methide intermediate.
Driscoll JP; Kornecki K; Wolkowski JP; Chupak L; Kalgutkar AS; O'Donnell JP
Chem Res Toxicol; 2007 Oct; 20(10):1488-97. PubMed ID: 17892269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
